The US FDA on Wednesday approved Revolution Medicines’ Rasonque for advanced pancreatic cancer, opening a new treatment option for patients with metastatic disease. A large trial found the once-daily pill doubled survival rates, offering fresh hope for people who have exhausted other treatments.
Trending
- US journalist injured during Israeli settler attack on West Bank olive harvest
- Uzbekistan signs $4.7bn energy deals and outlines plans for two more nuclear power plants
- EU champions homegrown AI as US, China retain lead
- Book Of The Dead Officially Set As Sequel Title
- Who was Jewish anti-fascist resistance fighter Eva Mamlok?
- Spring-summer 2027 ready-to-wear collections: Africa in the spotlight at Paris Fashion Week
- Snapchat, TikTok and Instagram grooming becoming ‘quicker and easier’
- Stunning ‘space jellyfish’ lights up night sky after SpaceX launch – but can YOU guess what it is?
